Immunohistochemical Expression of Cyclin D1 in Prostate Carcinoma

Kamil, Lubna Abdulsalam; Sahib, Muhsin Abd Ali

doi:10.52573/ipmj.2021.175786

	Immunohistochemical Expression of Cyclin D1 in Prostate Carcinoma
Iraqi Postgraduate Medical Journal
Article 6, Volume 21, Issue 3, 2022, Pages 288-292 PDF (835 K)
DOI: 10.52573/ipmj.2021.175786
Authors
Lubna Abdulsalam Kamil; Muhsin Abd Ali Sahib
Department of Pathology ,College of Medicine, University of Baghdad. Baghdad, Iraq
Abstract
BACKGROUND: Prostate carcinoma is one of the most common malignant tumors in men older than 50 years of age and is characterized by a highly variable clinical course. Cyclin D1 proto-oncogene is an important regulator of G1 to S phase progression in many different cell types AIM OF STUDY: To study the expression of cyclin D1 in prostate adenocarcinoma, and to evaluate the relationship of this protein with clinicopathological features (histological grade, perineural invasion, and preoperative PSA level). MATERIALS AND METHODS : This is retrospective study including 50 cases, forty cases diagnosed histopathology as prostate adenocarcinoma and 10 cases as a benign prostatic hyperplasia. These cases were collected from laboratory department of AL Shaheed Ghazi ALhariri hospital from November 2018 to May 2019. Type of biopsy is a needle core biopsy. RESULTS: The immunohistochemical expression of cyclin D1 was negative in benign prostatic hyperplasia, while in prostate adenocarcinoma 52.5% were positive .There was significant correlation between histological grade of prostate adenocarcinoma and immunohistochemical expression of cyclin D1 There was no association between immmunohistochemical expression of cyclin D1 in prostate adenocarcinoma with the presence of perineural invasion, and the pre –operative PSA level. CONCLUSION: Cyclin D1 expressed in prostate carcinoma and not in benign prostate hyperplasia. ma .
Keywords
cyclin D1 expression; Prostate carcino

References
Georgios M, Michael C, Ioannis A, Aida T, Theodosia C, and Charalampos D : Estrogen receptor(α&β) but not androgen receptor expression is correlated with recurrence, progression and survival in postprostactomy T3NOMO locally advanced prostate cancer in an urban Greek population.Asian J Androl 2004. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J , Roso S, and CoeberghJW:Cancer incidence and mortality patterns in Europe:estimates for 40 countries in 2012.Eur J Cancer 2013;49:1374-403. Rosai J. Rosai and Ackerman's surgical pathology e-book. Elsevier Health Sciences; 2011 Jun 20 ,chapter 26. Jeremy J, Deeba N, YewseokSuh, Chenelle R, Mohammad S, Imtiaz A, etal :Disruption of Androgen and Estrogen Receptor Activity in Prostate Cancer by a Novel Dietary DiterpeneCarnosol:Implication for Chemoprevention, Cancer Prev Res 2010;3:1112-23. Ekman P: Genetic and environmental factors in prostate cancer genesis: identifying highrisk cohorts. Eur Urol1999; 35:362. Hadi MA, Talha AA, Ahmed AS, Babiker AA. Cyclin D1 immunohistochemical expression in Sudanese patients affected with prostatic carcinoma in Khartoum State. Sudan Journal of Medical Sciences. 2018;13:289-300. Pereira RA, Ravinal RC, Costa RS, Lima MS, Tucci S, Muglia VF, Dos Reis RB, Silva GE. Cyclin D1 expression in prostate carcinoma. Brazilian Journal of Medical and Biological Research. 2014;47:515-21. Han EK, Lim JT, Arber N, Rubin MA, Xing WQ, Weinstein IB. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. The Prostate. 1998 ;35:95-101. Nakamura Y, Felizola SJ, Kurotaki Y, Fujishima F, McNamara KM, Suzuki T, et al. Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ERbeta) in human prostate cancer. Prostate 2013; 73: 590-595, doi: 10.1002/pros.22599. 10. Ahmed ES, Elnour LS, Hassan R, Siddig EE, Chacko ME, Ali ET, Mohamed MA, Munir A, Muneer MS, Mohamed NS, Edris AM. Immunohistochemical expression of Cyclin D1 among Sudanese patients diagnosed with benign and malignant prostatic lesions. BMC research notes. 2020 ;13:1-6. 11. Emin O¨zbek BM, Mustafa O¨zbek, Su¨leyman Bu¨yu¨kberberMD. Cyclin-D1 protooncogen expression in prostate cancer.Turkish J Cancer 2000 ; 30. 12. Drobnjak M, Osman I, Scher HI, Fazzari M, Cordon-Cardo C. Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clinical Cancer Research. 2000 ;6:1891-95.
Statistics Article View: 293 PDF Download: 122